{"DataElement":{"publicId":"3923501","version":"1","preferredName":"Disease or Disorder Status LymphomaType","preferredDefinition":"A description of the disease status of lymphoma.","longName":"2512861v1.0:3923411v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2512861","version":"1","preferredName":"Disease or Disorder Status","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time.","longName":"2404658v1.0:2320064v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898979-184A-3A90-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3923411","version":"1","preferredName":"Lymphoma Status Type","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._A condition or state at a particular time._Type; a subdivision of a particular kind of thing.","longName":"3923411v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CR1","valueDescription":"CR1 1st complete remission","ValueMeaning":{"publicId":"3061131","version":"1","preferredName":"CR1 1st complete remission","longName":"3061131","preferredDefinition":"1st complete remission: no bone marrow or extramedullary relapse prior to transplant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84497187-004C-5BD2-E040-BB89AD435B89","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"NYCHM","dateCreated":"2010-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9038248-46B7-AF6A-E040-BB89AD436679","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"CR2","valueDescription":"Integer::2 Complete Remission","ValueMeaning":{"publicId":"3104038","version":"1","preferredName":"Integer::2 Complete Remission","longName":"3104038","preferredDefinition":"A number with no fractional part.::2: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87ABD1F4-DE61-7475-E040-BB89AD4333B5","latestVersionIndicator":"Yes","beginDate":"2010-05-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9038248-46C1-AF6A-E040-BB89AD436679","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"CR3+","valueDescription":"Greater Than or Equal To Integer::3 Complete Remission","ValueMeaning":{"publicId":"3072089","version":"1","preferredName":"Greater Than or Equal To Integer::3 Complete Remission","longName":"3072089","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part.::3: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84B2D65C-DEFD-69FB-E040-BB89AD432401","latestVersionIndicator":"Yes","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9038248-46CB-AF6A-E040-BB89AD436679","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"CRU1","valueDescription":"CRU1 1st complete remission undetermined","ValueMeaning":{"publicId":"3061134","version":"1","preferredName":"CRU1 1st complete remission undetermined","longName":"3061134","preferredDefinition":"1st complete remission undetermined: as above with the exception of persistent scan abnormailities of unknown signifigance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84497187-00B5-5BD2-E040-BB89AD435B89","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"NYCHM","dateCreated":"2010-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9038248-46D5-AF6A-E040-BB89AD436679","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"CRU2","valueDescription":"CRU2 2nd complete remission undetermined","ValueMeaning":{"publicId":"3061135","version":"1","preferredName":"CRU2 2nd complete remission undetermined","longName":"3061135","preferredDefinition":"2nd complete remission undetermined","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84497187-00D8-5BD2-E040-BB89AD435B89","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"NYCHM","dateCreated":"2010-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9038248-46DF-AF6A-E040-BB89AD436679","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"CRU3+","valueDescription":"CRU3+ 3rd or subsequent complete remission undetermined","ValueMeaning":{"publicId":"3061136","version":"1","preferredName":"CRU3+ 3rd or subsequent complete remission undetermined","longName":"3061136","preferredDefinition":"3rd or subsequent complete remission undetermined","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84497187-00FB-5BD2-E040-BB89AD435B89","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"NYCHM","dateCreated":"2010-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9038248-46E9-AF6A-E040-BB89AD436679","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"Disease untreated","valueDescription":"Negation Therapy","ValueMeaning":{"publicId":"3061597","version":"1","preferredName":"Negation Therapy","longName":"3061597","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84902434-A37B-9A05-E040-BB89AD431C3A","latestVersionIndicator":"Yes","beginDate":"2010-04-19","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2010-04-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9038248-46F3-AF6A-E040-BB89AD436679","beginDate":"2010-04-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"PIF res","valueDescription":"Primary induction failure - resistant","ValueMeaning":{"publicId":"3091163","version":"1","preferredName":"Primary induction failure - resistant","longName":"3091163","preferredDefinition":"Primary induction failure - resistant: NEVER in COMPLETE remission but with stable or progressive disease on treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"871CF883-2F3D-4365-E040-BB89AD4364FF","latestVersionIndicator":"Yes","beginDate":"2010-05-21","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-48C9-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"PIF sen / PR1","valueDescription":"Primary induction failure - sensitive","ValueMeaning":{"publicId":"3091164","version":"1","preferredName":"Primary induction failure - sensitive","longName":"3091164","preferredDefinition":"Primary induction failure - sensitive: NEVER in COMPLETE remission but with partial remission on treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"871CF883-2F60-4365-E040-BB89AD4364FF","latestVersionIndicator":"Yes","beginDate":"2010-05-21","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-48D3-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"PIF unk","valueDescription":"PIF unk: Primary induction failure - sensitivity unknown","ValueMeaning":{"publicId":"3061139","version":"1","preferredName":"PIF unk: Primary induction failure - sensitivity unknown","longName":"3061139","preferredDefinition":"Primary induction failure - sensitivity unknown","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84497187-0164-5BD2-E040-BB89AD435B89","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"NYCHM","dateCreated":"2010-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-48DD-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL1 res","valueDescription":"1st Relapse-resistant","ValueMeaning":{"publicId":"3928436","version":"1","preferredName":"1st Relapse-resistant","longName":"3928436","preferredDefinition":"1st relapse-resistant: stable or progressive disease with treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-48E7-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-48FF-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL1 sen","valueDescription":"1st Relapse-sensitive","ValueMeaning":{"publicId":"3928437","version":"1","preferredName":"1st Relapse-sensitive","longName":"3928437","preferredDefinition":"1st relapse-sensitive:partial remission (if complete remission was acheived, classify as CR2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-4909-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-4921-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL1 unk","valueDescription":"REL1 unk: 1st Relapse- sensitivity unknown","ValueMeaning":{"publicId":"3928438","version":"1","preferredName":"REL1 unk: 1st Relapse- sensitivity unknown","longName":"3928438","preferredDefinition":"1st relapse- sensitivity unknown","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-492B-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-4943-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL1 unt","valueDescription":"1st Relapse-untreated","ValueMeaning":{"publicId":"3928439","version":"1","preferredName":"1st Relapse-untreated","longName":"3928439","preferredDefinition":"1st relapse-untreated: includes either bone marrow or extramedullary relapse","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-494D-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-4965-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL2 res","valueDescription":"2nd Relapse-resistant","ValueMeaning":{"publicId":"3928440","version":"1","preferredName":"2nd Relapse-resistant","longName":"3928440","preferredDefinition":"2nd relapse-resistant: stable or progressive disease with treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-496F-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-4987-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL2 sen","valueDescription":"2nd Relapse-sensitive","ValueMeaning":{"publicId":"3928441","version":"1","preferredName":"2nd Relapse-sensitive","longName":"3928441","preferredDefinition":"2nd relapse-sensitive: partial remission (if complete remission achieved, classify as CR3+)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-4991-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-49A9-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL2 unk","valueDescription":"2nd Relapse- sensitivity unknown","ValueMeaning":{"publicId":"3928442","version":"1","preferredName":"2nd Relapse- sensitivity unknown","longName":"3928442","preferredDefinition":"2nd relapse- sensitivity unknown","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-49B3-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-49CB-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL2 unt","valueDescription":"2nd Relapse-untreated.","ValueMeaning":{"publicId":"3928443","version":"1","preferredName":"2nd Relapse-untreated.","longName":"3928443","preferredDefinition":"2nd relapse-untreated: includes either bone marrow or extramedullary relapse","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-49D5-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-49ED-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL3+ res","valueDescription":"3rd or subsequent relapse-resistant","ValueMeaning":{"publicId":"3091171","version":"1","preferredName":"3rd or subsequent relapse-resistant","longName":"3091171","preferredDefinition":"3rd or subsequent relapse-resistant: stable or progressive disease with treatment.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"871CF883-3069-4365-E040-BB89AD4364FF","latestVersionIndicator":"Yes","beginDate":"2010-05-21","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-49F7-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL3+ sen","valueDescription":"3rd or subsequent relapse-sensitive","ValueMeaning":{"publicId":"3928444","version":"1","preferredName":"3rd or subsequent relapse-sensitive","longName":"3928444","preferredDefinition":"3rd or subsequent relapse-sensitive: partial remission (if complete remission achieved, classify as CR3+)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96A8E65-4A01-B964-E040-BB89AD437DDF","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-4A19-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL3+ unk","valueDescription":"REL3+ unk","ValueMeaning":{"publicId":"3091173","version":"1","preferredName":"REL3+ unk","longName":"3091173","preferredDefinition":"3rd relapse or greater-sensitivity unknown","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"871CF883-30AF-4365-E040-BB89AD4364FF","latestVersionIndicator":"Yes","beginDate":"2010-05-21","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E96A8E65-4A23-B964-E040-BB89AD437DDF","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"ONEDATA","dateModified":"2013-10-23","deletedIndicator":"No"},{"value":"REL3+ unt","valueDescription":"3rd or subsequent relapse-untreated","ValueMeaning":{"publicId":"3945664","version":"1","preferredName":"3rd or subsequent relapse-untreated","longName":"3945664","preferredDefinition":"3rd or subsequent relapse-untreated: includes either bone marrow or extramedullary relapse","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA71051E-C2D2-9CF8-E040-BB89AD433955","latestVersionIndicator":"Yes","beginDate":"2013-11-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EA71051E-C2EA-9CF8-E040-BB89AD433955","beginDate":"2009-10-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-05","modifiedBy":"ONEDATA","dateModified":"2013-11-05","deletedIndicator":"No"},{"value":"Currently undergoing induction treatment","valueDescription":"Currently Receiving Induction Therapy","ValueMeaning":{"publicId":"7144096","version":"1","preferredName":"Currently Receiving Induction Therapy","longName":"7144096","preferredDefinition":"An indication that an individual is receiving something at the present time.: The first choice of treatment for a particular type of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Currently Receiving","conceptCode":"C159274","definition":"An indication that an individual is receiving something at the present time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Induction Therapy","conceptCode":"C158876","definition":"The first choice of treatment for a particular type of cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C54E484-1CB3-273D-E053-F662850A2D07","latestVersionIndicator":"Yes","beginDate":"2020-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C569D4C-D526-2683-E053-F662850A140A","beginDate":"2020-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2955416","version":"1","preferredName":"Lymphoma Status Type","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003:A condition or state at a particular time.:Type; a subdivision of a particular kind of thing.","longName":"C3208:C25688:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7678F018-36E0-2680-E040-BB89AD4335E1","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"SCOTTLO","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9038248-46A1-AF6A-E040-BB89AD436679","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"KUMMEROA","dateModified":"2020-01-17","changeDescription":". Added PV for 2532. AK 2020-1-17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PreTed_prime_dis_hct_hodg_lym_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_prime_dis_hct_nhl_lym_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:diseaseStatusCode","type":"HCT_BRIDG","context":"NHLBI"},{"name":"LYMpre_dis_assess_prep_lym_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_HL_lym_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_NHL_lym_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_LYM_lym_stat","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the disease status o","type":"Preferred Question Text","description":"What was the disease status of lymphoma?","url":null,"context":"NHLBI"},{"name":"What was the disease status?","type":"Alternate Question Text","description":"What was the disease status?","url":null,"context":"NHLBI"},{"name":"What was the disease status?","type":"Application Standard Question Text","description":"What was the disease status?","url":null,"context":"NHLBI"},{"name":"BRIDG Mapping for CDE:3923501","type":"BRIDG Mapping Path","description":"PerformedDiagnosis.diseaseStatusCode WHERE PerformedDiagnosis.value = \"Hodgkin\"s Lymphoma\" AND PerformedDiagnosis > PerformedObservation.dateRange IS LESS THAN OR EQUAL TO PerformedSubstanceAdministration.dateRange AND PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"Administer Hematopoietic Cell Product{ Transplantation}\"","url":null,"context":"NHLBI"},{"name":"What is the current disease status? (HL and NHL)","type":"Alternate Question Text","description":"What is the current disease status? (HL and NHL)","url":null,"context":"NHLBI"},{"name":"What is the current disease status?","type":"Alternate Question Text","description":"What is the current disease status?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9052121-9085-91A8-E040-BB89AD435E35","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":".1/15/14mn-added BRIDG info.. 4/28/14mn-added alt name for 2018r3. Added human readable def. System generated def displayed as alt def. No version needed. AK 11/3/14. Added AQT. 04/09/2019 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}